AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions.
Since the merger it has been among the world’s largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, United Kingdom; Gothenburg, Sweden and Gaithersburg in Maryland, U.S. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Throughout the twentieth century, it grew into the largest pharmaceutical company in Sweden.
AstraZeneca PLC Financials at a glance including: EPS, Sales, Shares Outstanding, SPY Comparison, Short Interest, Short Interest History, EPS Performance and Forecast, GAAP EPS Performance and Forecast, Revenue Performance and Forecast, Price Reactions to Earnings Reports, Latest Revisions, Revenue by Products and Services, Revenue by Regions, Revenue by Segment, Dividends, and Dividend Payout History.
Please Note: Information edited and updated on 17/03/2025
Index – Major index membership
Market Cap – Market capitalization
Income – Trailing 12 months income
Sales – Trailing 12 months revenue
Book/sh – Most recent quarter book value a share
Cash/sh – Most recent quarter cash per share
Dividend Est. – Analysts’ dividend estimate (fiscal year)
Dividend TTM – Trailing 12-month dividend
Dividend Ex-Date – Ex-dividend date
Employees – Number of full-time employees
Option/Short – Stock has options on a market exchange/stock is available to sell short
Sales Surprise – Last quarter revenue surprise
SMA20 – Stock price distance from 20-day simple moving average
P/E – Price-to-Earnings (trailing 12-months)
Forward P/E – Forward Price-to-Earnings (next fiscal year)
PEG – Price-to-Earnings-to-Growth
P/S – Price-to-Book (most recent quarter)
P/B – Price-to-Book (most recent quarter)
P/C – Price to cash per share (most recent quarter)
P/FCF – Price to Free Cash Flow (trailing 3-months)
Quick Ratio – Quick Ratio (most recent quarter)
Current Ratio – Current Ratio (most recent quarter)
Debt/Eq – Total Debt to Equity (most recent quarter)
LT Debt/Eq – Long Term Debt to Equity (most recent quarter)
EPS Surprise – Last quarter Earnings-Per-Share surprise
SMA50 – Stock price distance from 50-Day Simple Moving Average
EPS (ttm) – Diluted Earnings-Per-Share (trailing 3-months)
EPS next Y – Earnings-Per-Share estimate for next year
EPS next Q – Earnings-Per-Share estimate next quarter
EPS this Y - Earnings-Per-Share growth this year
EPS next Y - Earnings-Per-Share estimate for next year
EPS next 5Y – Long term annual growth estimate (5 years)
EPS past 5Y – Annual Earnings-Per-Share growth past 5 years
Sales past 5Y – Annual sales growth past 5 years
EPS Y/Y TTM – Earnings-Per-Share growth (trailing 3 months)
Sales Y/Y TTM – Sales growth (trailing 3 months)
EPS Q/Q – Quarterly earnings growth (Year-on-Year)
Sales Q/Q – Quarterly revenue growth (Year-on-Year)
SMA200 – Stock price distance from 2-Day Simple Moving Average
Insider Own – Percentage insider ownership of company shares
Insider Trans – Insider transactions (6-month change in Insider Ownership)
Inst Own – Institutional ownership
Inst Trans - Institutional transactions (3-month change in Institutional Ownership)
ROA – Return on Assets (trailing 3-months)
ROE – Return on Equity (trailing 3-months)
ROI – Return on Investment (trailing 3-months)
Gross Margin – Gross Margin (trailing 3-months)
Oper. Margin – Operating Margin (trailing 3-months)
Profit Margin – Net Profit Margin (trailing 3-months)
Payout – Dividend Payout Ratio (trailing 3-months)
Earnings – BMO = Before Market Open / AMC = After Market Close
Shs Outstand – Shares outstanding
Shs Float – Shares float
Short Float – Short interest share
Short Ratio – Short interest ratio
Short Interest – Short interest
52W Range – 52-Week trading range
52W High – Distance from 52-Week High
52W Low - Distance from 52-Week Low
RSI (14) – Relative Strength Index
Perf Week – Performance (Week)
Perf Month – Performance (Month)
Perf Quarter – Performance (Quarter)
Perf Half Y - Performance (Half Year)
Perf Year – (Year)
Perf YTD - Performance (Year-To-Date)
Beta - Beta
ATR (14) – Average True Range
Volatility – Volatility (Week, Month)
Target Price – Analysts’ mean target price
Price – Current stock price
